Cramer Gives His Opinion On Cloudera, Barrick Gold And More


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


On CNBC's "Mad Money Lightning Round," Jim Cramer said Zuora Inc (NYSE:ZUO) is struggling because it has real competition.

Albireo Pharma Inc (NASDAQ:ALBO) is a totally speculative stock, said Cramer. Even if the company hits it out of the park, you won't make much money, thinks Cramer.

Thermo Fisher Scientific Inc. (NYSE:TMO) and Danaher Corporation (NYSE:DHR) are both better companies than Bruker Corporation (NASDAQ:BRKR), said Cramer.

Instead of Cloudera Inc (NYSE:CLDR), Cramer would rather buy Snowflake Inc (NYSE:SNOW). He said Cloudera doesn't have growth and he is not looking for value in that segment.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) is an inexpensive stock and it is going to stay inexpensive because it doesn't have any growth, said Cramer.

Cramer likes salesforce.com, inc. (NYSE:CRM) and he is going to continue to like it as long as Marc Benioff is there.

Cramer would buy Barrick Gold Corp (NYSE:GOLD) on this pullback.


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: MediaCNBCJim Cramermad money Lightning Round